In light of the change in recommendation regarding the administration of COVID-19 AstraZeneca in those under 50 years, we are excited to be hosting a special clinical feature event on Thrombosis with thrombocytopenia syndrome (TTS) & COVID-19 AstraZeneca. Our panel will be giving background on what this new syndrome is and explore its association with the vaccine. We will also discuss the risk-versus-benefit assessment and how this new recommendation will impact confidence in the vaccine rollout.
The session will run for approximately 1.5 hours, including an opportunity for live Q&A from the audience.
To register for our special clinical feature event, please follow these steps:
- Sign up if you are a new user or Sign in to your profile to access the event.
- Once you have Signed up/Signed in, please click ‘take this course’ to enrol into this event. The event details and links will then be accessible.
- A confirmation email will be sent to your nominated email address confirming your registration and will also include the Zoom link for the event.